B0JL93
Gene name |
tig |
Protein name |
Trigger factor |
Names |
TF, PPIase |
Species |
Microcystis aeruginosa (strain NIES-843 / IAM M-2473) |
KEGG Pathway |
mar:MAE_62700 |
EC number |
5.2.1.8: Cis-trans isomerases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for B0JL93
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-B0JL93-F1 | Predicted | AlphaFoldDB |
No variants for B0JL93
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for B0JL93 | |||||
1 associated diseases with B0JL93
[MIM: 619694]: Developmental delay with variable neurologic and brain abnormalities (DENBA)
An autosomal dominant disorder characterized by onset of motor and speech delay in early childhood. Disease severity and clinical manifestations are highly variable. Most patients have delayed walking and variably impaired intellectual development. Additional features may include seizures, spasticity, and ocular abnormalities. Brain imaging often shows thin corpus callosum and may show white matter atrophy, myelination abnormalities, or enlarged ventricles. {ECO:0000269|PubMed:32820033}. Note=The disease is caused by variants affecting the gene represented in this entry.
Without disease ID
- An autosomal dominant disorder characterized by onset of motor and speech delay in early childhood. Disease severity and clinical manifestations are highly variable. Most patients have delayed walking and variably impaired intellectual development. Additional features may include seizures, spasticity, and ocular abnormalities. Brain imaging often shows thin corpus callosum and may show white matter atrophy, myelination abnormalities, or enlarged ventricles. {ECO:0000269|PubMed:32820033}. Note=The disease is caused by variants affecting the gene represented in this entry.
Functions
| Description | ||
|---|---|---|
| EC Number | 5.2.1.8 | Cis-trans isomerases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| peptidyl-prolyl cis-trans isomerase activity | Catalysis of the reaction: peptidyl-proline (omega=180) = peptidyl-proline (omega=0). |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| cell cycle | The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. |
| cell division | The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells. |
| protein folding | The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure. |
| protein transport | The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MKVIQEKLPA | SQIGLEIEIP | AETTKNTHEQ | VVKNLAKSVN | IPGFRPGKVP | RQILLQRLGT |
| 70 | 80 | 90 | 100 | 110 | 120 |
| KAVKAAVIEE | LIENCLESAL | KQEGIESLGN | PQLLSKFEDL | IAAYEPGKAL | TFSVSLDVAP |
| 130 | 140 | 150 | 160 | 170 | 180 |
| TIILGDYENL | SVTAEETVYD | PESVENWFKE | RQEQLATLVP | VEDRGAQLGD | VAIVDYRGKS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| AETGEDIPDI | DGEDLRVDME | AGRFIEGMVE | GIIGMKPEEV | KEMTLTFPED | YPKEDVAAKA |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VIFTITMKEL | KAKELPELDD | DFAQEVSDQE | TIAELRASLE | KRFQEQAEKE | TKESIDDALT |
| 310 | 320 | 330 | 340 | 350 | 360 |
| KELVKGATLD | LPETLIEKEV | THILTQSFMQ | FQQMGLDVNQ | LFTKDNIPKM | RENARPDAIE |
| 370 | 380 | 390 | 400 | 410 | 420 |
| SLKETLVVQE | LAKVAGIEVS | PEAVAEKIAN | IMSQLSDRDI | DMQRLEQVIT | EEMLAENTLE |
| 430 | 440 | 450 | 460 | ||
| WLKEKATITL | VPKGSLEEET | SEEEETEETL | AAAAVEVLAA | EEEP |